SQLite Web: event

seq

Primary key. INTEGER

id

TEXT NOT NULL

kind

TEXT NOT NULL

ts

TEXT NOT NULL

actor

TEXT

subject_entity_ids

TEXT

payload

{"artifact_id":"artf_thesis_ab3ee0ef4be9b04a","evidence_event_ids":["evt_8ad8cf6b0498","evt_748f94635af8","evt_7df7bc422d50"],"kind":"opportunity_thesis","meta":{"confidence":0.46,"lane":"monitor","morning_holdback":false,"rank_score":0.46,"theme_keys":[],"urgency_reason":"not_urgent","urgent":false},"output_json":{"artifact_kind_detail":"research_thesis","catalysts":[],"confidence":0.46,"decision_reason_codes":["research_thesis","evidence_form4_insider_rsu_vesting_schedule_provided","no_directional_operational_update_in_filing","theme_membership_not_established_for_ycbD"],"headline":"On 2026-04-16, cbdMD, Inc. filed Form 4 disclosing that William F. Raines III received RSUs representing contingent rights to receive one share each, vesting quarterly from June 30, 2026 to March 31, 2027.","investigation_questions":["Do later YCBD SEC filings (Form 4s, 10-Q/10-K, 8-Ks) show any operational/strategic announcements that cluster around the disclosed vesting dates (June 30, 2026; Sep 30, 2026; Dec 31, 2026; Mar 31, 2027)?","Are there prior instances where YCBD insider equity grants with similar vesting schedules coincided with measurable changes in guidance, revenue trajectory, or risk disclosures?","What is the context of the \u201ccontingent rights\u201d language for Raines\u2019 RSUs\u2014does it tie to performance, service conditions, or other contingencies that could affect timing or interpretation?","How do these RSU grants compare to YCBD\u2019s historical pattern of equity compensation (frequency, size, and vesting cadence) for insiders and executives?","Is there any discrepancy between the Form 4 disclosures and other contemporaneous corporate communications (e.g., investor presentations or press releases) regarding incentives, governance, or compensation philosophy?"],"portfolio_fit":{"applied":false,"boost":0.0,"exit_risk_flagged":false,"hedge_suggested":null,"matched_holdings":[],"matched_watchlist":[],"stub_version":"v1","why_you":""},"related_tickers":["YCBD"],"risk_level":"medium","theme_keys":[],"thesis":"The Form 4 RSU vesting schedule creates a measurable future timeline for YCBD\u2019s internal equity incentives (Raines and Scott), which can be used as a structured \u201cwatch window\u201d for subsequent company updates and market repricing. While the filing itself is neutral, the specificity of vesting dates provides a concrete framework to investigate whether YCBD\u2019s operational or strategic milestones cluster around these periods."},"ready_at":"2026-04-17T03:26:51.628880+00:00","status":"ready","summary":"The Form 4 RSU vesting schedule creates a measurable future timeline for YCBD\u2019s internal equity incentives (Raines and Scott), which can be used as a structured \u201cwatch window\u201d for subsequent company updates and market repricing. While the filing itself is neutral, the specificity of vesting dates provides a concrete framework to investigate whether YCBD\u2019s op","title":"[THESIS] YCBD \u2014 On 2026-04-16, cbdMD, Inc. filed Form 4 disclosing that William F. Raines III received RSUs representing contingent rights to receive one share each, vesting quarterly from June 30, 20","updated_at":"2026-04-17T03:26:51.628880+00:00"}

TEXT NOT NULL

source_ref

TEXT

confidence

REAL (default 0.0

dedupe_key

TEXT

episode_id

TEXT

created_at

TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')

event_store.db — events

Update row 61945 in events